Univeristy of Nebraska-Lincoln (UNL) scientist Ana Maria Vélez is pioneering a genetic treatment to contain western corn rootworm. The research seeks to contain agricultural pests by targeting ...
Report covers Silexion Therapeutics (NASDAQ: SLXN), a disruptive player in the precision oncology space, developing innovative RNAi therapies targeting KRAS-driven cancers, highlighting the company’s ...
Our RNAi play came from the understanding that personalization and the development of curated therapies are the future of ...
Significant progress in bulk RNA sequencing, methylation mapping, multiomics integration, and spatial analyses unlocks ...
Dublin-based Aerska launched on Wednesday with $21 million in seed funding and a technology designed to shuttle RNA ...
LONDON--(BUSINESS WIRE)--Silexion Therapeutics (NASDAQ: SLXN) has emerged an intriguing yet under the radar player in the precision oncology space, focusing on developing innovative RNA interference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback